Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review

Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review

© 2017 Elsevier Ltd Background Globally, most patients with hypertension are treated with monotherapy, and control rates are poor because monotherapy only reduces blood pressure by around 9/5 mm Hg on average. There is a pressing need for blood pressure-control strategies with improved efficacy and...

Full description

Bibliographic Details
Main Authors: Chow, C., Thakkar, J., Bennett, A., Hillis, G., Burke, M., Usherwood, T., Vo, K., Rogers, K., Atkins, E., Webster, R., Chou, M., Dehbi, H., Salam, A., Patel, A., Neal, B., Peiris, D., Krum, H., Chalmers, J., Nelson, M., Reid, Christopher, Woodward, M., Hilmer, S., Thom, S., Rodgers, A.
Format: Journal Article
Published: The Lancet Publishing Group 2017
Online Access:http://hdl.handle.net/20.500.11937/62266

Similar Items

Similar Items